Latest Conference Coverage
Use of these agents is associated with a much lower incidence of hypercalcemia compared with the use of calcium carbonate or calcium acetate.
Meta-analysis reveals a significantly increased risk of kidney stones only in male patients with kidney cancer.
Calciphylaxis was 75% less likely to develop in patients who received the drug rather than placebo.
Over 52 weeks, the drug maintained hemoglobin levels while decreasing IV iron use in dialysis patients with anemia.
Researchers in the Netherlands report results from an autopsy study of diabetic nephropathy patients.
In adjusted analyses, serum phosphorus levels independently predicted glucose disposal rate.
Benefit seen among anemia and hemodialysis patients with hemoglobin levels below 10 g/dL.
Each 0.5 mg/dL increment in serum phosphorus associated with 58% increased odds of coronary heart failure (CHF).
Aspirin and clonidine increased the risk of major bleeding and clinically important hypotension in acute kidney injury (AKI).
Renal events are significantly less likely if erythropoiesis-stimulating agents are started at hemoglobin levels below 11 g/dL.
Tight blood pressure control slows the rate of increase in total kidney volume and reduces left ventricular index.
Periodontal disease is associated with a significant 4.2-fold greater incidence of chronic kidney disease (CKD).
Rates for infection-, gastrointestinal-, and cardiac-related adverse events are lower than with sevelamer carbonate or calcium acetate.
New finding on vitamin B6 is the opposite of what investigators hypothesized on patients with anemia.
Plant-based diet had the lowest urinary phosphorus excretion, whereas an inorganic-based diet had the highest.
Study shows a significantly better 5-year cancer-specific survival rate compared with radical cystectomy.
Use of the drug reduced the risk of recurrence and cancer-related mortality in diabetic patients undergoing radical cystectomy.
Transient rises in PSA after radiotherapy may be due to late damage to healthy prostatic tissue, evidence suggests.
Increased long-term risk observed in men on active surveillance.
At its annual meeting, the American Urological Association provided details of its first guidelines for the medical management of urolithiasis.
Study compared surgeons who performed fewer than 100 robot-assisted radical prostatectomies with those who performed 100 or more.
Single-institution study finds most patients satisfied with the results and would have the surgery again.
Allowing 1, 2, or 3 or more days between the first and second injection of collagenase clostridium histolyticum does not impact efficacy.
This parameter can identify prostate cancer patients for whom adjuvant radiation therapy after radical prostatectomy may be of no benefit.
Detecting fluoroquinolone-resistant organisms may allow for targeted antibiotic prophylaxis and identification of men at risk for infection.
The risk of cancer-specific death at 1 year was 48% and 23% for patients whose disease recurred at 3 months and 3 years, respectively.
Patients should be selected carefully because of a higher incidence of locally advanced disease and regional lymph node metastases.
Researchers compared transurethral resection of the prostate with prostate artery embolization in a randomized trial.
PSA bounce was associated with significantly higher scores on the International Index of Erectile Function-15 questionnaire.
Study reveals a late recurrence rate of 3% and 5% at 15 and 20 years, respectively, after radiotherapy.
- Optimal PSA Threshold For Targeted Biopsy Identified
- Plant-Based Phosphorus Best for Kidney Disease (CKD) Patients
- Testosterone Replacement Therapy (TRT) Beneficial in Diabetes Mellitus Patients
- Stopping Renal Cell Carcinoma (mRCC) Drugs Induces Tumor Flare
- Red Meat Contributes to Cardiovascular Disease (CVD) Risk Due to Gut Bacteria
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)